The SELECT Study Makes One Thing Undeniable: Obesity Is a Chronic, Treatable Disease

The New England Journal of Medicine published full results today from the SELECT study of semaglutide to prevent cardiovascular deaths, strokes, and heart attacks in people with obesity. This landmark study makes one thing unmistakable: obesity is a chronic, treatable disease. Comprehensive and effective treatment saves and transforms lives. With this data in hand, it is plain that denying people access to care for obesity adds up to a rationalization for preventing people the opportunity to live healthier, longer lives.